|
|
|
| Clinical effect of intratracheal instillation of Bovine Pulmonary Surfactant for Injection combined with Budesonide in the treatment of neonatal respiratory distress syndrome |
| LIU Pan-li1 LUO Hong-bin1 LIAO Zhi-wei1 HU Min2▲ YANG Rui-fen1 LIU Wei-yun1 HU Yu1 XIAO Xiao-xing1 |
1. Department of Neonatology, Xinyu People′s Hospital, Jiangxi Province, Xinyu 338025, China;
2. Emergency Rescue Center of Xinyu City, Jiangxi Province 338025, China |
|
|
|
|
Abstract Objective To study the clinical effect of intratracheal instillation of Bovine Pulmonary Surfactant for Injection combined with Budesonide in the treatment of neonatal respiratory distress syndrome (NRDS). Methods Sixty children with NRDS admitted to the Department of Neonatology of Xinyu People′s Hospital from May 2017 to May 2019 were selected as subjects. They were divided into control group (n=30) and observation group (n=30) by lottery. The control group was treated with Bovine Pulmonary Surfactant for Injection, while the observation group was treated with intratracheal instillation of Bovine Pulmonary Surfactant for Injection combined with Budesonide. The blood gas analysis, clinical manifestations, oxygen saturation (SpO2), heart rate, invasive mechanical ventilation rate, mechanical ventilation time, hospital stay, biparietal diameter (BPD) incidence and total complication rate were observed. Results After treatment, arterial oxygen partial pressure (PaO2) and pH value of the observation group were higher than those of the control group, and mechanical blood carbon dioxide partial pressure ( PaCO2) was lower than that of the control group,the differences were statistically significant (P＜0.05). The scores of clinical manifestations including polypnea, groan,three concave signs, and complexion in the observation group were lower than those of the control group, the differences were statistically significant (P＜0.05). The SpO2 in the observation group was higher than that in the control group, and the heart rate was lower than that in the control group, the differences were statistically significant (P＜0.05).In the observation group, the invasive mechanical ventilation rate was lower, the mechanical ventilation time and hospital stay were shorter, and the incidence of BPD and the total incidence of complications were lower compared with those in the control group, the differences were statistically significant (P＜0.05). Conclusion Intratracheal instillation of Bovine Pulmonary Surfactant for Injection combined with Budesonide for children with NRDS can effectively improve blood gas analysis and clinical symptoms, reduce the invasive mechanical ventilation rate, the incidence of BPD and complications, and shorten mechanical ventilation time and hospital stay, which is worthy of promotion.
|
|
|
|
|
|
| Cite this article: |
|
LIU Pan-li,LUO Hong-bin,LIAO Zhi-wei, et al. Clinical effect of intratracheal instillation of Bovine Pulmonary Surfactant for Injection combined with Budesonide in the treatment of neonatal respiratory distress syndrome[J]. 中国当代医药, 2020, 27(7): 121-124.
|
|
|
|
| URL: |
| http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I7/121 |
| [1] |
王小娟，张西嫔，赵智，等.CPAP 联合珂立苏治疗新生儿呼吸窘迫综合征（RDS）的临床研究[J].世界中医药，2016，11（B3）：1113-1114.
|
| [2] |
李凌，张志红，张慧琴，等.持续气道正压呼吸联合珂立苏治疗新生儿呼吸窘迫综合征的疗效观察[J].中南医学科学杂志，2017，45（5）：499-502.
|
| [3] |
曹芳，潘家华.欧洲早产儿呼吸窘迫综合征治疗共识指南——2010年更新版[J].安徽医药，2010，14（12）：1525-1530.
|
| [4] |
刘敬，李静雅，韩涛，等.珂立苏治疗足月新生儿呼吸窘迫综合征临床研究[J].中国小儿急救医学，2014，21（5）：259-262.
|
| [5] |
章晔，陈筱青.珂立苏联合CPAP 治疗新生儿呼吸窘迫综合征的疗效观察[J].中国妇幼保健，2015，30（32）：5676-5679.
|
| [6] |
柯华，李占魁，于西萍，等.不同剂型布地奈德联合肺表面活性物质治疗新生儿呼吸窘迫综合征疗效的比较[J].中国当代儿科杂志，2016，18（5）：400-404.
|
| [7] |
邓黎静，彭华保，龚晓琴.布地奈德联合肺表面活性物质治疗重症呼吸窘迫综合征对支气管肺发育不良的影响[J].中国新生儿科杂志，2017，32（5）：361-364.
|
| [8] |
李霞.珂立苏治疗新生儿呼吸窘迫综合征的护理体会[J].检验医学与临床，2014，25（Z1）：171-172.
|
| [9] |
Li C，Zha O GF，He QY，et al.Study on the clinical efficacy of Human Urinary Kalllikrein in the treatment of acute cerebral infarction according to TOAST classification[J].Pak J Pharm Sci，2015，28（4 Suppl）：1505-1510.
|
| [10] |
El-Tatawy H，Gameel T，El-enen MA，et al.Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride[J].Arch Ital Urol Androl，2015，87（3）：238-242.
|
| [11] |
Schjerning Olsen AM，Fosb l EL，Pallisgaard J，et al.NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction：a nationwide study[J].Eur Heart J Cardiovasc Pharmacother，2015，1（2）：107-114.
|
| [12] |
张纪伟.肺表面活性物质治疗新生儿呼吸窘迫综合征的临床疗效分析[J].临床医学，2017，37（3）：113-114.
|
| [13] |
高金红.PS 治疗新生儿MAS 和NRDS 的疗效观察及安全性评价[J].临床肺科杂志，2015，20（11）：2080-2082.
|
| [14] |
李群，倪文昌，邬慧明，等.肺表面活性物质联合布地奈德预防新生儿呼吸窘迫综合征的疗效观察[J].海军医学杂志，2019，40（1）：54-57.
|
| [15] |
任志红.肺表面活性物质联合布地奈德预防极低出生体质量儿支气管肺发育不良的疗效分析[J].中国妇幼保健，2019，34（4）：815-819.
|
|
|
|
